89BIO (ETNB) News Today $10.00 +0.06 (+0.60%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$10.00 0.00 (0.00%) As of 06/18/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETNB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Assenagon Asset Management S.A. Increases Holdings in 89bio, Inc. (NASDAQ:ETNB)Assenagon Asset Management S.A. raised its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 76.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 428,895 shares of the company's stock after buying an aJune 16, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Trading Up 4.9% - What's Next?89bio (NASDAQ:ETNB) Trading Up 4.9% - Here's What HappenedJune 13, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Down 4.8% - Here's What Happened89bio (NASDAQ:ETNB) Shares Down 4.8% - Here's WhyJune 12, 2025 | marketbeat.comHarbor Capital Advisors Inc. Buys 62,874 Shares of 89bio, Inc. (NASDAQ:ETNB)Harbor Capital Advisors Inc. grew its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 25.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 314,772 shares of the company's stock after acquiring an additionaJune 12, 2025 | marketbeat.comWeiss Ratings Reaffirms Sell (D-) Rating for 89bio (NASDAQ:ETNB)June 12, 2025 | americanbankingnews.com89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss RatingsWeiss Ratings restated a "sell (d-)" rating on shares of 89bio in a report on Wednesday.June 12, 2025 | marketbeat.comCantor Fitzgerald Estimates 89bio FY2026 EarningsJune 12, 2025 | americanbankingnews.comBrokers Offer Predictions for 89bio FY2026 Earnings89bio, Inc. (NASDAQ:ETNB - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of 89bio in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse anticipates that the company will earn ($2.87) per share for the yeJune 11, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 26.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 178,691 sJune 9, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Raises Position in 89bio, Inc. (NASDAQ:ETNB)Hennion & Walsh Asset Management Inc. grew its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 48.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 140,306 shares of the company's stock after puJune 7, 2025 | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.com89bio to Participate in Goldman Sachs 46th Annual Global Healthcare ConferenceJune 4, 2025 | globenewswire.comTwo Sigma Investments LP Sells 131,167 Shares of 89bio, Inc. (NASDAQ:ETNB)Two Sigma Investments LP lessened its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 35.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 237,521 shares of the company'sJune 3, 2025 | marketbeat.comTwo Sigma Advisers LP Reduces Holdings in 89bio, Inc. (NASDAQ:ETNB)Two Sigma Advisers LP trimmed its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 31.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 112,100 shares of the company's stock after selling 51,100 shares duringJune 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by Bank of America Corp DEBank of America Corp DE grew its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 10.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 358,574 shares of the company's stock after acquiring an additional 3June 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of "Buy" by BrokeragesShares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have received a consensus recommendation of "Buy" from the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating anJune 1, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Up 6.4% - Still a Buy?89bio (NASDAQ:ETNB) Trading 6.4% Higher - Here's WhyMay 30, 2025 | marketbeat.com89bio (ETNB) Receives a Buy from Bank of America SecuritiesMay 29, 2025 | theglobeandmail.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's What Happened89bio (NASDAQ:ETNB) Shares Gap Up - What's Next?May 29, 2025 | marketbeat.comMillennium Management LLC Has $5.54 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)Millennium Management LLC grew its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 85.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 708,196 shares of the company's stock after purchasing an additional 3May 29, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 3.3% - Here's What Happened89bio (NASDAQ:ETNB) Shares Down 3.3% - What's Next?May 28, 2025 | marketbeat.com89bio's (ETNB) "Sell (D-)" Rating Reaffirmed at Weiss RatingsWeiss Ratings reaffirmed a "sell (d-)" rating on shares of 89bio in a research report on Saturday.May 28, 2025 | marketbeat.comWoodline Partners LP Grows Stake in 89bio, Inc. (NASDAQ:ETNB)Woodline Partners LP grew its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 640.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 394,826 shares of the company's stock after acquiring an additional 341,479 shares during the quarteMay 27, 2025 | marketbeat.comRafferty Asset Management LLC Has $694,000 Stake in 89bio, Inc. (NASDAQ:ETNB)Rafferty Asset Management LLC lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 30.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 88,745 shares of the company's stock after selling 38,636 shares during the period. Rafferty Asset ManagMay 25, 2025 | marketbeat.comNorthern Trust Corp Increases Stake in 89bio, Inc. (NASDAQ:ETNB)Northern Trust Corp lifted its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 7.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 854,787 shares of the company's stock after acquiring an additional 60,075 shares during the period.May 22, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) is Suvretta Capital Management LLC's 8th Largest PositionSuvretta Capital Management LLC lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 27.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,202,696 shares of the company's stock after purchasingMay 19, 2025 | marketbeat.comRTW Investments LP Increases Stake in 89bio, Inc. (NASDAQ:ETNB)RTW Investments LP boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 1.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 7,478,061 shares of the company's stock after purchasing an additional 99,513 shares during the quarter.May 18, 2025 | marketbeat.comBNP Paribas Financial Markets Takes Position in 89bio, Inc. (NASDAQ:ETNB)BNP Paribas Financial Markets purchased a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 351,331 shares of the company's stock, valued at approximately $2,747,000. BNP ParMay 18, 2025 | marketbeat.comDimensional Fund Advisors LP Buys New Stake in 89bio, Inc. (NASDAQ:ETNB)Dimensional Fund Advisors LP purchased a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 342,229 shares of the company's stock, valued at approximately $2,67May 17, 2025 | marketbeat.comJanus Henderson Group PLC Boosts Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)Janus Henderson Group PLC grew its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 8.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,514,056 shares of the company's stock after purchasing aMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Has $7.82 Million Holdings in 89bio, Inc. (NASDAQ:ETNB)Integral Health Asset Management LLC increased its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 100.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,000,000 shares of the company's stock after buyinMay 14, 2025 | marketbeat.comIs Now the Time to Buy Biotech Stocks?May 13, 2025 | finance.yahoo.comBalyasny Asset Management L.P. Purchases Shares of 1,019,449 89bio, Inc. (NASDAQ:ETNB)Balyasny Asset Management L.P. acquired a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 1,019,449 shares of the company's stock, valued at approximately $7,97May 12, 2025 | marketbeat.comAlgert Global LLC Boosts Stock Position in 89bio, Inc. (NASDAQ:ETNB)Algert Global LLC lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 198.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 185,407 shares of the company's stock after purchasing an additional 123,190 shares duringMay 12, 2025 | marketbeat.comWeiss Ratings Reaffirms "Sell (D-)" Rating for 89bio (NASDAQ:ETNB)Weiss Ratings restated a "sell (d-)" rating on shares of 89bio in a research note on Saturday.May 12, 2025 | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 9, 2025 | globenewswire.comDeep Track Capital LP Buys 3,711,737 Shares of 89bio, Inc. (NASDAQ:ETNB)Deep Track Capital LP increased its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 134.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,478,249 shares of the company's stock after purchasing an additional 3,711,737 shMay 9, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Alyeska Investment Group L.P.Alyeska Investment Group L.P. increased its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 14.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 925,397 shares of the company's stock after buying an aMay 8, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of "Buy" by Brokerages89bio, Inc. (NASDAQ:ETNB - Get Free Report) has been assigned a consensus rating of "Buy" from the nine research firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendationMay 8, 2025 | marketbeat.com89bio to Participate in Upcoming Investor ConferencesMay 6, 2025 | globenewswire.com89bio, Inc. (NASDAQ:ETNB) Shares Sold by BVF Inc. ILBVF Inc. IL trimmed its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 36.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,333,885 shares of the company's stock after selling 2,477,746 shares during the quMay 6, 2025 | marketbeat.com60,992 Shares in 89bio, Inc. (NASDAQ:ETNB) Purchased by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC acquired a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 60,992 shares of the company's stocMay 6, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS89bio (NASDAQ:ETNB - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.50) by $0.01. During the same period in the prior year, the firm posted ($0.54) earnings per share.May 5, 2025 | marketbeat.comEquities Analysts Issue Forecasts for 89bio FY2025 Earnings89bio, Inc. (NASDAQ:ETNB - Free Report) - Cantor Fitzgerald issued their FY2025 earnings per share estimates for 89bio in a research note issued on Wednesday, April 30th. Cantor Fitzgerald analyst S. Seedhouse expects that the company will earn ($3.35) per share for the year. Cantor Fitzgerald hMay 4, 2025 | marketbeat.comAlly Bridge Group NY LLC Takes Position in 89bio, Inc. (NASDAQ:ETNB)Ally Bridge Group NY LLC purchased a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 317,833 shares of the company's stock, valued aMay 4, 2025 | marketbeat.comPDT Partners LLC Cuts Stake in 89bio, Inc. (NASDAQ:ETNB)PDT Partners LLC reduced its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 52.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,918 shares of the company's stock after selling 88,327 shares dMay 4, 2025 | marketbeat.comCantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to "Strong-Buy"Cantor Fitzgerald raised shares of 89bio to a "strong-buy" rating in a research note on Wednesday.May 3, 2025 | marketbeat.com89bio (ETNB) Projected to Post Quarterly Earnings on Thursday89bio (NASDAQ:ETNB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-89bio-inc-stock/)May 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 525,000 Shares of 89bio, Inc. (NASDAQ:ETNB)Adage Capital Partners GP L.L.C. lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 60.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 350,000 shares of the company's stock after selling 525,000 sMay 2, 2025 | marketbeat.com89bio Reports First Quarter 2025 Financial Results and Corporate UpdatesMay 1, 2025 | globenewswire.com Get 89BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼1.080.69▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼35▲ETNB Articles Average Week Get 89BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Telix Pharmaceuticals Limited American Depositary Shares News TG Therapeutics News Nuvalent News Lantheus News Axsome Therapeutics News ADMA Biologics News Zai Lab News Akero Therapeutics News Vaxcyte News PTC Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89BIO Please log in to your account or sign up in order to add this asset to your watchlist. Share 89BIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.